1. Search Result

Search Result

Pathways Recommended: PI3K/Akt/mTOR
Targets Recommended: Akt

Results for "Akt/PKB 抑制剂" in MCE Product Catalog:

201

Inhibitors & Agonists

3

Screening Libraries

9

Peptides

68

Natural
Products

Cat. No. Product Name Target Research Area
  • HY-P0141
    Akt/SKG Substrate Peptide

    Peptides Others
    Akt/SKG Substrate Peptide 是一种合成的 Akt/PKB 底物肽,不会被 p70S6K 或 MAPK1 磷酸化。
  • HY-P0141A
    Akt/SKG Substrate Peptide TFA

    Peptides Others
    Akt/SKG Substrate Peptide TFA 是一种合成的 Akt/PKB 底物肽,不会被 p70S6K 或 MAPK1 磷酸化。
  • HY-P1115A
    AKTide-2T TFA

    Akt Others
    AKTide-2T TFA 是一个优良的体外 AKT 底物,可竞争性抑制组蛋白 H2B 磷酸化,其 Ki 值为 12 nM。AKTide-2T TFA 模拟 Akt 的最佳磷酸化序列,是一种抑制肽,是 S22 位置中缺失了野生型 AKTide。
  • HY-P1277
    GR 94800

    Neurokinin Receptor Neurological Disease
    GR 94800 是有效的、选择性的神经激肽 2 (NK2) 受体的肽类拮抗剂,其对 NK2、NK1 和 NK3 受体的 pKB 值分别为 9.6、6.4 和 6.0。
  • HY-P1277A
    GR 94800 TFA

    Neurokinin Receptor Neurological Disease
    GR 94800 TFA 是有效的、选择性的神经激肽 2 (NK2) 受体的肽类拮抗剂,其对 NK2、NK1 和 NK3 受体的 pKB 值分别为 9.6、6.4 和 6.0。
  • HY-P0315
    Crosstide

    Akt Others
    Crosstide 是一种糖原合成酶激酶α/β融合蛋白序列的模拟肽,是 Akt 的底物。
  • HY-P2285
    AC 253

    Amyloid-β
    AC 253 is an Amylin (AMY3) receptor antagonist, inhibiting andrenomedulin-stimulated cAMP production. AC 253 protects against oligomeric Aβ-induced increase in intracellular Ca2+, activation of PKA, MAPK, Akt and cFOS and cell death in neuronal cell culture. AC 253 blocks electrophysiological effects of Aβ.
  • HY-P2196
    ELA-32(human)

    Peptides
    ELA-32(human) is a potent, high affinity apelin receptor agonist (IC50=0.27 nM; Kd=0.51 nM). ELA-32(human) exhibits no binding GPR15 and GPR25. ELA-32(human) activates the PI3K/AKT pathway and promotes self-renewal of hESCs via cell-cycle progression and protein translation. ELA-32(human) also potentiates the TGFβ pathway, priming hESCs toward the endoderm lineage. ELA-32(human) stimulates angiogenesis in HUVEC cells.
  • HY-P2196A
    ELA-32(human) TFA

    Peptides
    ELA-32(human) TFA is a potent, high affinity apelin receptor agonist (IC50=0.27 nM; Kd=0.51 nM). ELA-32(human) TFA exhibits no binding GPR15 and GPR25. ELA-32(human) TFA activates the PI3K/AKT pathway and promotes self-renewal of hESCs via cell-cycle progression and protein translation. ELA-32(human) TFA also potentiates the TGFβ pathway, priming hESCs toward the endoderm lineage. ELA-32(human) TFA stimulates angiogenesis in HUVEC cells.